Clayton, 2002 - Google Patents
Cultured Dendritic Cells for Cancer ImmunotherapyClayton, 2002
- Document ID
- 13594394951266799663
- Author
- Clayton A
- Publication year
- Publication venue
- PQDT-Global
External Links
Snippet
There is increasing interest in the development of targeted therapies for malignant disease, mainly as a result of the shortcomings of conventional chemotherapy for most solid malignancies. Immunological therapies are being developed, including monoclonal …
- 210000004443 Dendritic Cells 0 title abstract description 378
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
- A61K2039/5158—Antigen-pulsed cells, e.g. T-cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
- A61K2039/5154—Antigen presenting cells [APCs], e.g. dendritic cells, macrophages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
- A61K2039/5152—Tumor cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0636—T lymphocytes
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6230208B2 (en) | Stimulation of anti-tumor immunity using dendritic cell / tumor cell fusions and anti-CD3 / CD28 | |
| US10226519B2 (en) | Cancer vaccines and vaccination methods | |
| Panelli et al. | Phase 1 study in patients with metastatic melanoma of immunization with dendritic cells presenting epitopes derived from the melanoma-associated antigens MART-1 and gp100 | |
| Lau et al. | Phase I trial of intravenous peptide-pulsed dendritic cells in patients with metastatic melanoma | |
| Charbonnier et al. | Human acute myeloblastic leukemia cells differentiate in vitro into mature dendritic cells and induce the differentiation of cytotoxic T cells against autologous leukemias | |
| JP2011504101A5 (en) | ||
| US7198948B2 (en) | Methods and compositions for obtaining mature dendritic cells | |
| US20240374728A1 (en) | T Cell Modification | |
| CA2410510A1 (en) | Artificial antigen presenting cells and methods of use thereof | |
| CA2977836A1 (en) | Compositions and methods of treating cancer | |
| AU2016243192A1 (en) | Compositions and methods of treating renal cell cancer | |
| AU2017240584A1 (en) | Dendritic cell- extracellular vesicle fusions and methods of using same | |
| AU2016243626A1 (en) | Compositions and methods of treating multiple myeloma | |
| Radford et al. | Vaccine strategies to treat lymphoproliferative disorders | |
| Clayton | Cultured Dendritic Cells for Cancer Immunotherapy | |
| Theng | The development and characterization of CD1a [superscript]+ dendritic cells from CD34 [superscript]+ progenitor cells isolated from human umbilical cord blood. |